Aarhus, Denmark

Shervin Bahrami

This inventor holds 4 USPTO granted patents and 9 published patent applications and 2 EPO patents. Top assignees: Aarhus Universitet, Isd Immunotech Aps, Aimvion A/s. Active years: 2013-2022.

USPTO Granted Patents = 4 

% Patents Active = 25.0

 

Average Co-Inventor Count = 2.1

ph-index = 1

Forward Citations = 4(Granted Patents)


Location History:

  • Tilst, DK (2021)
  • Aarhus C, DK (2013 - 2022)

Company Filing History:


Years Active: 2013-2022

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Shervin Bahrami: Innovator in Immunology

Introduction

Shervin Bahrami is a notable inventor based in Aarhus C, Denmark. He has made significant contributions to the field of immunology, holding a total of 4 patents. His work focuses on immune suppression and inflammation reduction, showcasing his dedication to advancing medical science.

Latest Patents

Bahrami's latest patents include innovative uses of immune suppressive domains as medicaments. This invention concerns the application of immune suppressive domains (ISD) for immune suppression and the reduction of inflammation. Additionally, he has developed novel immunostimulating peptides, peptide constructs, and compositions, along with methods of treatment utilizing these peptides.

Career Highlights

Throughout his career, Shervin Bahrami has worked with esteemed organizations such as Aarhus Universitet and Isd Immunotech ApS. His experience in these institutions has allowed him to further his research and contribute to the scientific community.

Collaborations

Bahrami has collaborated with notable colleagues, including Finn Skou Pedersen and Mogens Ryttergaard Duch. These partnerships have enriched his work and expanded the impact of his inventions.

Conclusion

Shervin Bahrami's contributions to immunology through his patents and collaborations highlight his role as an influential inventor in the field. His innovative approaches to immune suppression and inflammation reduction continue to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…